Company intelligence / Profile preview

Cryterion Medical

Carlsbad, California, United States

Ownership: Private
Development stage: Other

Overview

Cryterion Medical was a medical device company dedicated to developing a next-generation cryoablation platform for the treatment of atrial fibrillation (AFib). The company's core technology is a cryoablation balloon catheter system designed to enhance the efficiency and safety of pulmonary vein isolation procedures. In 2018, Boston Scientific acquired the remaining 75% stake in the company for $202 million to strengthen its electrophysiology portfolio. The technology developed by Cryterion Medical served as the foundation for the Boston Scientific POLARx Cryoablation System, which is now commercially available globally.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

Boston Scientific

Beyond the preview

Go deeper on Cryterion Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cryterion Medical.

Explore the full profile